Documentation Centre

 

 

  of 291 Next page

Go to page: of

Screenshot Date Categories Title Author Format
A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015 Jan;145(1):177S-83S April 21, 2015 A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015 Jan;145(1):177S-83S Gower BA, Goss AM Key Publications
Obesity: Obesity turns the hepatic epigenetic clock forward. Nat Rev Endocrinol. 2015;11:2 April 16, 2015 Obesity: Obesity turns the hepatic epigenetic clock forward. Nat Rev Endocrinol. 2015;11:2 Sargent J Key Publications
Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2015;64:60-78 April 14, 2015 Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2015;64:60-78 Polyzos SA, Kountouras J, Mantzoros CS Key Publications
What does increased visceral adiposity reflect? April 08, 2015 What does increased visceral adiposity reflect? André Tchernof, PhD, Department of Nutrition, Université Laval, Endocrinology and Genomics axis, Laval University Medical Centre, Québec, QC, Canada Expert Opinions
Video 0:52 min.
(4 MB)
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res. 2014;55:2676-84 March 31, 2015 Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res. 2014;55:2676-84 Männistö VT, Simonen M, Soininen P, Tiainen M, Kangas AJ, Kaminska D, Venesmaa S, Käkelä P, Kärjä V, Gylling H, Ala-Korpela M, Pihlajamäki J Key Publications
Ectopic fat and cardiometabolic health: an update March 16, 2015 Ectopic fat and cardiometabolic health: an update The International Chair on Cardiometabolic Risk Webcasts
Video 0:10 min.
(55 MB)
What is the role of subcutaneous adipose tissue in terms of quality and expandability in cardiometabolic diseases? March 16, 2015 What is the role of subcutaneous adipose tissue in terms of quality and expandability in cardiometabolic diseases? Amalia Gastaldelli, PhD, Research Director, Cardiometabolic Risk Laboratory, Institute of Clinical Physiology of CNR, Pisa, Italy Expert Opinions
Video 0:40 min.
(3 MB)
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384:1953-97 March 13, 2015 Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384:1953-97 Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, et al. Key Publications
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism. 2014;63:1542-52 March 10, 2015 Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism. 2014;63:1542-52 Wree A, Schlattjan M, Bechmann LP, Claudel T, Sowa JP, Stojakovic T, Scharnagl H, Köfeler H, Baba HA, Gerken G, Feldstein AE, Trauner M, Canbay A Key Publications
Periaortic fat and cardiovascular risk: a comparison of high-risk older adults and age-matched healthy controls. Int J Obes (Lond). 2014;38:1397-402 March 04, 2015 Periaortic fat and cardiovascular risk: a comparison of high-risk older adults and age-matched healthy controls. Int J Obes (Lond). 2014;38:1397-402 Brinkley TE, Leng X, Chughtai HL, Nicklas BJ, Kritchevsky SB, Ding J, Kitzman DW, Hundley WG Key Publications

  of 291 Next page

Go to page: of